Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 61: Which cardiac biomarker is the most appropriate choice for the diagnosis of myocardial infarction 10 days after the initial event?

A. Troponins (Correct Answer)
B. CK-MB
C. Myoglobin
D. LDH

Explanation: **Explanation:** The diagnosis of Myocardial Infarction (MI) relies on the temporal patterns of cardiac biomarkers. **Troponins (specifically Cardiac Troponin I and T)** are the gold standard for diagnosis due to their high sensitivity and specificity. **1. Why Troponins are correct:** Troponins begin to rise 3–6 hours after myocardial injury. While Troponin I remains elevated for **7–10 days**, **Troponin T** can remain elevated for up to **10–14 days**. This prolonged elevation makes them the most appropriate choice for diagnosing a "late" or subacute MI when the patient presents several days after the initial event. **2. Why other options are incorrect:** * **CK-MB:** This isoenzyme rises 4–8 hours after injury but returns to baseline within **48–72 hours**. It is the investigation of choice for diagnosing **re-infarction** but is useless 10 days post-event. * **Myoglobin:** This is the **earliest** marker to rise (1–3 hours) but lacks specificity and returns to normal within **24 hours**. * **LDH (Lactate Dehydrogenase):** Specifically the LDH-1 isoenzyme, it peaks at 3–4 days and returns to normal by day 10–14. While it stays elevated longer than CK-MB, Troponins have replaced it in modern clinical practice due to superior cardiac specificity. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Marker:** Myoglobin. * **Most Specific Marker:** Troponin I. * **Marker for Re-infarction:** CK-MB. * **LDH Flip:** In MI, LDH-1 becomes higher than LDH-2 (normally LDH-2 > LDH-1). * **Troponin T** can be falsely elevated in patients with chronic kidney disease (CKD).

Question 62: Conjugated bilirubin is increased in which of the following conditions?

A. Rotor Syndrome (Correct Answer)
B. Gilbert syndrome
C. Crigler-Najjar syndrome type 1
D. Crigler-Najjar syndrome type 2

Explanation: ### Explanation The key to answering this question lies in distinguishing between **pre-microsomal** (unconjugated) and **post-microsomal** (conjugated) hyperbilirubinemia. **1. Why Rotor Syndrome is Correct:** Rotor Syndrome is an autosomal recessive condition characterized by a defect in the **hepatic storage and excretion** of bilirubin into the bile canaliculi. Specifically, there is a deficiency in the OATP1B1 and OATP1B3 transporters. Since the bilirubin has already been processed by the enzyme UDP-glucuronosyltransferase (UGT) in the liver, it is **conjugated** (water-soluble). However, because it cannot be excreted properly, it leaks back into the blood, leading to conjugated hyperbilirubinemia. **2. Why the Other Options are Incorrect:** * **Gilbert Syndrome:** Caused by a mild reduction in UGT1A1 activity (approx. 30% of normal). It results in **unconjugated** hyperbilirubinemia, often triggered by fasting or stress. * **Crigler-Najjar Syndrome Type 1:** A total absence of UGT1A1 activity. It leads to severe, life-threatening **unconjugated** hyperbilirubinemia and kernicterus. * **Crigler-Najjar Syndrome Type 2 (Arias Syndrome):** A partial deficiency of UGT1A1 activity. It causes moderate **unconjugated** hyperbilirubinemia but is less severe than Type 1. **3. Clinical Pearls for NEET-PG:** * **Conjugated Hyperbilirubinemia:** Think of **Dubin-Johnson** (black liver due to melanin-like pigment) and **Rotor Syndrome** (normal liver color). * **Unconjugated Hyperbilirubinemia:** Think of **Gilbert** and **Crigler-Najjar** (defects in conjugation) or Hemolysis (overproduction). * **Urine Findings:** Conjugated bilirubin is water-soluble and appears in urine (**bilirubinuria**), whereas unconjugated bilirubin is bound to albumin and cannot pass into urine. * **Differentiating Test:** In Rotor syndrome, there is a marked increase in total urinary coproporphyrin levels, whereas in Dubin-Johnson, the total level is normal but the proportion of Coproporphyrin I is high (>80%).

Question 63: Which of the following tests is done to detect the presence of urobilinogen?

A. Guthrie test
B. Fouchet's test
C. Ehrlich's test (Correct Answer)
D. Alcian blue spot test

Explanation: **Explanation** The correct answer is **C. Ehrlich’s test**. **1. Why Ehrlich’s test is correct:** Ehrlich’s reagent contains **p-dimethylaminobenzaldehyde** in concentrated hydrochloric acid. When added to urine containing urobilinogen, it reacts to form a characteristic **cherry-red colored complex**. Urobilinogen is a colorless byproduct of bilirubin reduction by intestinal bacteria; its presence in urine is a sensitive indicator of liver dysfunction or hemolytic anemias. **2. Analysis of Incorrect Options:** * **A. Guthrie test:** This is a semi-quantitative bacterial inhibition assay used for neonatal screening of **Phenylketonuria (PKU)**. It detects elevated levels of phenylalanine in the blood. * **B. Fouchet's test:** This test is used to detect **Bile Pigments (Bilirubin)** in urine. Ferric chloride in Fouchet’s reagent oxidizes bilirubin to biliverdin, producing a green/blue color. * **D. Alcian blue spot test:** This is a screening test used to detect **Mucopolysaccharides (Glycosaminoglycans)** in urine, typically used when investigating Mucopolysaccharidoses (e.g., Hurler syndrome). **3. Clinical Pearls for NEET-PG:** * **Fresh Urine Requirement:** Ehrlich’s test must be performed on a fresh urine sample because urobilinogen is rapidly oxidized to urobilin (which does not react with the reagent) upon exposure to air and light. * **Differential Diagnosis:** * **Hemolytic Jaundice:** Urinary urobilinogen is **increased** (increased heme breakdown). * **Obstructive Jaundice:** Urinary urobilinogen is **absent** (bile cannot reach the gut for conversion). * **False Positives:** Porphobilinogen (PBG) also reacts with Ehrlich’s reagent. The **Watson-Schwartz test** is used to differentiate between the two (urobilinogen is soluble in chloroform, while PBG is not).

Question 64: Cystatin C is a novel marker of?

A. Fatty liver
B. Vitamin K status
C. Glomerular filtration (Correct Answer)
D. Cholestasis

Explanation: **Explanation:** **Cystatin C** is a low-molecular-weight protein (13 kDa) produced at a constant rate by all nucleated cells in the body. It belongs to the cysteine protease inhibitor family. It is freely filtered by the **glomerulus**, is not secreted by the renal tubules, and although it is reabsorbed and metabolized by proximal tubular cells, it does not re-enter the blood. Therefore, its serum concentration is inversely proportional to the **Glomerular Filtration Rate (GFR)**. **Why Option C is correct:** Unlike Creatinine, Cystatin C levels are independent of muscle mass, age, gender, or dietary intake (protein consumption). This makes it a more sensitive and reliable marker for detecting early changes in GFR, particularly in the "creatinine-blind" range (mild to moderate renal impairment). **Why other options are incorrect:** * **A. Fatty Liver:** Markers for fatty liver (NAFLD) typically include ALT, AST, and imaging/fibroscan results, not Cystatin C. * **B. Vitamin K Status:** This is assessed via Prothrombin Time (PT/INR) or PIVKA-II levels. * **D. Cholestasis:** This is characterized by elevations in Alkaline Phosphatase (ALP), Gamma-Glutamyl Transferase (GGT), and Conjugated Bilirubin. **High-Yield Clinical Pearls for NEET-PG:** * **Superiority:** Cystatin C is superior to Serum Creatinine in patients with liver cirrhosis, extreme malnutrition, or amputations where muscle mass is significantly reduced. * **Limitation:** Its levels can be affected by thyroid dysfunction (increased in hyperthyroidism) and high-dose corticosteroid therapy. * **Pediatrics:** It is particularly useful in pediatric populations where muscle mass varies significantly with growth.

Question 65: The xylose absorption test is used to assess:

A. Insulinoma
B. Atypical carcinoid
C. Zollinger-Ellison syndrome
D. Monosaccharide absorption (Correct Answer)

Explanation: **Explanation:** The **D-xylose absorption test** is a classic diagnostic tool used to evaluate the integrity of the proximal small intestinal mucosa and to differentiate between different causes of malabsorption. **Why the correct answer is right:** D-xylose is a **pentose monosaccharide** that is absorbed via passive diffusion in the proximal small intestine. Unlike complex carbohydrates, it does not require pancreatic enzymes (amylase) or bile salts for digestion. Therefore, if D-xylose levels are low in the blood or urine after oral administration, it indicates **mucosal damage** (e.g., Celiac disease, Tropical sprue) rather than pancreatic insufficiency. It specifically tests the capacity of the intestine to absorb monosaccharides. **Why the other options are incorrect:** * **Insulinoma:** This is a pancreatic islet cell tumor causing hypoglycemia due to excessive insulin secretion. Diagnosis involves the 72-hour fast and C-peptide levels. * **Atypical Carcinoid:** Carcinoid tumors are neuroendocrine tumors secreting serotonin. Diagnosis involves measuring 5-HIAA in urine. * **Zollinger-Ellison Syndrome (ZES):** ZES is caused by a gastrinoma leading to excessive gastric acid. While ZES can cause secondary malabsorption due to acid-induced inactivation of pancreatic enzymes, the D-xylose test is not the primary diagnostic tool (Secretin stimulation test is used). **NEET-PG High-Yield Pearls:** * **Normal Result:** High urinary excretion of D-xylose (>4g in 5 hours) suggests the intestinal mucosa is intact (points toward Pancreatic Insufficiency if malabsorption is present). * **Abnormal Result:** Low urinary excretion suggests **Mucosal disease** (e.g., Celiac disease). * **False Positives:** Low urinary D-xylose can occur in **Renal failure**, **Ascites**, or **Small Intestinal Bacterial Overgrowth (SIBO)** (bacteria metabolize the xylose before absorption).

Question 66: Why is Troponin C not used for myocardial infarction diagnosis?

A. Troponin C binds to calcium.
B. Troponin C is present in both cardiac and smooth muscle. (Correct Answer)
C. Troponin C is present in both cardiac and skeletal muscle.
D. It elevates late after the onset of myocardial infarction.

Explanation: **Explanation:** The diagnosis of Myocardial Infarction (MI) relies on the detection of biomarkers that are highly specific to cardiac tissue. The Troponin complex consists of three subunits: **Troponin T (Trop-T)**, **Troponin I (Trop-I)**, and **Troponin C (Trop-C)**. The correct answer is **Option B**. Troponin C is not used clinically because it lacks tissue specificity. While Troponin I and T have unique cardiac isoforms (cTnI and cTnT) that differ from skeletal muscle isoforms, **Troponin C is identical in both cardiac and slow-twitch skeletal muscle**. Therefore, an elevation in Troponin C could indicate either cardiac injury or skeletal muscle damage, making it an unreliable diagnostic tool for MI. **Analysis of Incorrect Options:** * **Option A:** While Troponin C does bind to calcium (initiating contraction), this is its physiological function and not the reason it is excluded as a biomarker. * **Option C:** This is partially true but less precise than the biochemical reality that it is shared specifically with slow-twitch skeletal fibers. However, in the context of standard NEET-PG patterns, the lack of cardiac-specific isoforms is the primary disqualifier. * **Option D:** Troponin C does not necessarily elevate "late"; it is simply not measured because it cannot differentiate the source of muscle injury. **NEET-PG High-Yield Pearls:** * **Gold Standard:** Cardiac Troponins (cTnI and cTnT) are the preferred markers for MI due to high sensitivity and specificity. * **Timeline:** Troponins rise within **3–6 hours**, peak at **12–24 hours**, and remain elevated for **7–10 days** (cTnI) or up to **14 days** (cTnT). * **Re-infarction:** **CK-MB** is the marker of choice for diagnosing a second MI occurring shortly after the first, as it returns to baseline within 48–72 hours.

Question 67: What is the temporal profile of detection of serum enzymes in acute myocardial infarction?

A. CPK, SGOT, LDH (Correct Answer)
B. SGOT, CPK, LDH
C. CPK, LDH, SGOT
D. SGOT, LDH, CPK

Explanation: In Acute Myocardial Infarction (AMI), cardiac enzymes are released into the bloodstream at specific intervals following myocardial necrosis. The correct sequence of detection depends on the **temporal profile** (rise, peak, and duration) of these enzymes. ### 1. Why Option A is Correct The sequence **CPK → SGOT → LDH** reflects the chronological order in which these enzymes rise above the baseline: * **CPK (Creatine Phosphokinase):** Specifically the MB isoenzyme (CK-MB). It is the earliest of the three to rise, typically appearing within **4–6 hours** of chest pain. It peaks at 24 hours and returns to normal within 2–3 days. * **SGOT (Serum Glutamic Oxaloacetic Transaminase):** Also known as AST. It begins to rise within **6–12 hours**, peaks at 24–48 hours, and returns to normal within 4–6 days. * **LDH (Lactate Dehydrogenase):** This is a late marker. It begins to rise within **12–24 hours**, peaks at 48–72 hours, and remains elevated for up to 10–14 days. ### 2. Why Other Options are Incorrect * **Options B & D:** Incorrect because they place SGOT before CPK. CPK is always the earliest enzyme to rise among these three. * **Option C:** Incorrect because it suggests LDH rises before SGOT. LDH is the largest molecule among these and takes the longest time to leak into the circulation and reach detectable levels. ### 3. High-Yield Clinical Pearls for NEET-PG * **Earliest Marker:** **Myoglobin** is the earliest marker (rises in 1–2 hours), but it is non-specific. * **Gold Standard:** **Cardiac Troponins (I and T)** are the most sensitive and specific markers. They rise within 3–6 hours (similar to CK-MB) but stay elevated for 7–14 days. * **Re-infarction:** **CK-MB** is the investigation of choice for detecting re-infarction because it returns to baseline quickly (within 72 hours), unlike Troponins. * **LDH Flip:** In AMI, LDH1 becomes higher than LDH2 (normally LDH2 > LDH1), known as the "flipped pattern."

Question 68: Conjugated hyperbilirubinemia is seen in which of the following conditions?

A. Breast milk jaundice
B. Dubin-Johnson syndrome (Correct Answer)
C. Crigler-Najjar syndrome
D. Gilbert syndrome

Explanation: **Explanation:** Hyperbilirubinemia is classified into unconjugated (pre-microsomal/microsomal) and conjugated (post-microsomal) based on where the defect occurs in the bilirubin metabolism pathway. **Why Dubin-Johnson Syndrome is Correct:** Dubin-Johnson syndrome is an autosomal recessive disorder caused by a mutation in the **MRP2 protein** (Multidrug Resistance-associated Protein 2). This protein is responsible for the ATP-dependent transport of conjugated bilirubin from hepatocytes into the bile canaliculi. When this transport is defective, conjugated bilirubin leaks back into the blood, leading to **conjugated hyperbilirubinemia**. A hallmark feature is a **black-colored liver** due to the accumulation of epinephrine metabolites. **Why Other Options are Incorrect:** * **Breast milk jaundice:** Caused by substances in breast milk (like beta-glucuronidase) that increase the enterohepatic circulation of bilirubin, leading to **unconjugated hyperbilirubinemia**. * **Crigler-Najjar syndrome:** Caused by a total (Type I) or partial (Type II) deficiency of the enzyme **UDP-glucuronosyltransferase (UGT1A1)**. Since bilirubin cannot be conjugated, it results in severe **unconjugated hyperbilirubinemia**. * **Gilbert syndrome:** A common, mild condition characterized by reduced activity of **UGT1A1**. It results in episodic, mild **unconjugated hyperbilirubinemia**, often triggered by stress or fasting. **High-Yield Clinical Pearls for NEET-PG:** * **Rotor Syndrome:** Similar to Dubin-Johnson (conjugated hyperbilirubinemia) but **lacks** the black liver pigmentation and has different urinary coproporphyrin excretion patterns. * **Urine Test:** Conjugated bilirubin is water-soluble and can appear in urine (bilirubinuria), whereas unconjugated bilirubin is bound to albumin and cannot pass the glomerular filter. * **Enzyme Deficiency Mnemonic:** **G**ilbert and **C**rigler-Najjar involve the **G**lucuronidation step (Unconjugated). **D**ubin-Johnson and **R**otor involve **D**iscretion/Excretion (Conjugated).

Question 69: Which of the following is the biochemical marker of choice for cholestatic jaundice of pregnancy?

A. Serum Bilirubin
B. Bile acids (Correct Answer)
C. Bile salts
D. Alkaline phosphatase levels

Explanation: **Explanation:** **Intrahepatic Cholestasis of Pregnancy (ICP)** is a reversible form of cholestasis occurring typically in the third trimester, characterized by intense pruritus (especially of palms and soles) without a rash. **Why Bile Acids are the Correct Answer:** The biochemical hallmark and the most sensitive marker for diagnosing and monitoring ICP is the elevation of **Total Serum Bile Acids (TSBA)**. In ICP, there is a defect in the excretion of bile acids into the bile canaliculi, leading to their accumulation in the blood. A level >10 µmol/L is diagnostic, and levels >40 µmol/L are associated with increased fetal risk (preterm birth, meconium staining, and stillbirth). **Why Other Options are Incorrect:** * **Serum Bilirubin:** While it may be elevated in some cases (clinical jaundice), it is an insensitive marker. Most patients with ICP remain non-icteric. * **Bile Salts:** While often used interchangeably in casual conversation, "Bile Acids" is the precise biochemical term used in diagnostic assays. Bile salts are the conjugated form found in the intestine. * **Alkaline Phosphatase (ALP):** ALP levels naturally increase during pregnancy (3-4 times) due to the production of the placental isoenzyme. Therefore, it lacks the specificity required to diagnose cholestasis in a pregnant patient. **Clinical Pearls for NEET-PG:** * **Primary Symptom:** Pruritus (worse at night) without a primary skin rash. * **Treatment of Choice:** **Ursodeoxycholic acid (UDCA)**, which helps lower bile acid levels and relieves itching. * **Fetal Risk:** The main concern is sudden intrauterine fetal death (IUFD) due to bile acid toxicity to the fetal myocardium. * **Resolution:** Symptoms and biochemical markers typically resolve rapidly after delivery.

Question 70: Microalbuminuria is defined as protein levels of:

A. 30-300 mg/d (Correct Answer)
B. 151-200 mg/d
C. 100-150 mg/d
D. 301-600 mg/d

Explanation: **Explanation:** Microalbuminuria refers to the excretion of albumin in the urine at a rate higher than normal but below the detection limit of a standard dipstick test. It is a critical clinical marker for early-stage diabetic nephropathy and cardiovascular risk. **1. Why Option A is Correct:** The standard clinical definition of microalbuminuria is the excretion of **30–300 mg of albumin over a 24-hour period**. In a healthy individual, the glomerular filtration barrier prevents most albumin from entering the filtrate; thus, normal excretion is <30 mg/day. When the barrier begins to fail (often due to hyperglycemia-induced basement membrane damage), levels rise into the 30–300 mg/day range. **2. Why Other Options are Incorrect:** * **Options B and C (100–200 mg/d):** These ranges fall *within* the spectrum of microalbuminuria but do not define its lower or upper limits. They are subsets, not the diagnostic criteria. * **Option D (301–600 mg/d):** Excretion **>300 mg/day** is classified as **Macroalbuminuria** (or overt proteinuria). At this stage, protein becomes detectable on a routine urine dipstick. **Clinical Pearls for NEET-PG:** * **ACR (Albumin-to-Creatinine Ratio):** Since 24-hour collection is cumbersome, a spot urine ACR is preferred. Microalbuminuria is defined as an ACR of **30–300 mg/g**. * **Reversibility:** This stage is clinically significant because it is the last point where renal damage may be reversible with strict glycemic control and ACE inhibitors/ARBs. * **Screening:** In Type 2 Diabetes, screen at the time of diagnosis. In Type 1 Diabetes, screen 5 years after diagnosis.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free